A Study of NWY001 in Subjects With Advanced Solid Tumors

Clinical trial NCT05979155 · RECRUITING

Trial details

NCT number: NCT05979155
Sponsor: Chipscreen Biosciences, Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-01-05
Primary completion: 2026-01-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.